Corrigendum: Hepatic de Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene (Journal of Clinical Endocrinology and Metabolism (2015) 100:8 (E1125-E1132) DOI: 10.1210/jc.2015-1587);Hepatic de novo lipogenesis in obese youth is modulated by a common variant in the GCKR gene

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages E1125-E1132

  Santoro, Nicola ^a   Caprio, Sonia ^a   Pierpont, Bridget ^a   Van Name, Michelle ^a   Savoye, Mary ^a   Parks, Elizabeth J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT OBESITY; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GCKR GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE OXIDATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID OXIDATION; LIPOGENESIS; LIVER METABOLISM; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; CHILDHOOD OBESITY; COHORT ANALYSIS; COMPLICATION; CONTROLLED CLINICAL TRIAL; FATTY LIVER; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GLYCOLYSIS; INDIRECT CALORIMETRY; LIVER; METABOLISM;

GCKR PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; CALORIMETRY, INDIRECT; COHORT STUDIES; FATTY LIVER; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLYCOLYSIS; HUMANS; LIPOGENESIS; LIVER; MALE; PEDIATRIC OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84939168174     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/clinem/dgz158     Document Type: Erratum

References (28)

1. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343-1351.
2. Chambers JC, Zhang W, Sehmi J, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 2011;43:1131-1138.
3. Santoro N, Zhang CK, Zhao H, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology. 2012;55:781-789.
4. Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7:e1001324.
5. Brown KS, Kalinowski SS, Megill JR, Durham SK, Mookhtiar KA. Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus. Diabetes. 1997;46:179-186.
6. Agius L, Peak M. Binding and translocation of glucokinase in hepatocytes. Biochem Soc Trans. 1997;25:145-150.
7. de la Iglesia N, Mukhtar M, Seoane J, Guinovart JJ, Agius L. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte. J Biol Chem. 2000;275:10597-10603.
8. Rees MG, Wincovitch S, Schultz J, et al. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia. 2012;55:114-122.
9. Beer NL, Tribble ND, McCulloch LJ, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet. 2009;18:4081-4088.
10. Santoro N, Feldstein AE, Enoksson E, et al. The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants. Diabetes Care. 2013;36:1353-1360.
11. Santoro N, Caprio S, Giannini C, et al. Oxidized fatty acids: a potential pathogenic link between fatty liver and type 2 diabetes in obese adolescents? Antioxid Redox Signal. 2014;20:383-389.
12. Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146:726-735.
13. Donnelly KL, Margosian MR, Sheth SS, Lusis AJ, Parks EJ. Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/- mice. J Nutr. 2004;134:1475-1480.
14. Parks EJ, Skokan LE, Timlin MT, Dingfelder CS. Dietary sugars stimulate fatty acid synthesis in adults. J Nutr. 2008;138:1039-1046.
15. Flannery C, Dufour S, Rabøl R, Shulman GI, Petersen KF. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes. 2012;61:2711-2717.
16. Gasic S, Schneider B, Waldhäusl W. Indirect calorimetry: variability of consecutive baseline determinations of carbohydrate and fat utilization from gas exchange measurements. Horm Metab Res. 1997;29:12-15.
17. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab. 2006;91:1446-1452.
18. Hellerstein MK, Neese RA. Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am J Physiol. 1999;276:E1146-E1170.
19. D'Adamo E, Cali AM, Weiss R, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care. 2010;33:1817-1822.
20. Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab. 2004;89:1096-1101.
21. Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology. 2009;49:1896-1903.
22. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287-293.
23. Le Floch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L. Blood glucose area under the curve. Methodological aspects. Diabetes Care. 1990;13:172-175.
24. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
25. Arden C, Petrie JL, Tudhope SJ, et al. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis. Diabetes. 2011;60:3110-3120.
26. Stefanovski D, Youn JH, Rees M, et al. Estimating hepatic glucokinase activity using a simple model of lactate kinetics. Diabetes Care. 2012;35:1015-1020.
27. van de Bunt M, Gloyn AL. From genetic association to molecular mechanism. Curr Diab Rep. 2010;10:452-466.
28. Meininger GE, Scott R, Alba M, et al. Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. Diabetes Care. 2011;34:2560-2566.